NCT04851119 2026-02-24Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsChildren's Oncology GroupPhase 1/2 Recruiting147 enrolled
NCT05031897 2025-10-30Two Step Haplo With Radiation ConditioningThomas Jefferson UniversityPhase 2 Recruiting63 enrolled